The inability to breathe is unfortunately the most common cause of death in people living with Motor Neurone Disease (MND). Last year, our clinical research group in Melbourne reported that breathing assistance overnight (noninvasive ventilation or NIV) increases average survival by 13 months. Also importantly, it appeared that respiratory function and strength tests might allow us to target when is the best time to start NIV; too early and there is too much patient and carer burden, too late and benefit is lost. Our results and recent UK data further suggest that respiratory muscle strength tests could function as "biomarkers" that would help researchers better target when to test new therapies and drugs in MND. Before we can translate these findings into practice, the results must be checked in a separate but similar group. We propose to extend our existing cohort to 2016 (25 years of data) to test the UK results and to use Australian Motor Neurone Disease Register data on people outside Victoria to check our Victorian findings. These experiments will increase our ability to run clinical trials that find effects and will provide specific estimates of when to start NIV so that clinicians can best advise individual people with MND about exactly when breathing assistance overnight should be started.
Translation of Respiratory Biomarkers into MND Practice
Consider making a donation to help us learn more about breathlessness and other disorders. You can make an important contribution to the work of our research teams through a financial donation.
Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...
SHIFT WORK AND BREASTFEEDING PROJECT
Researchers at Austin Health are looking for volunteers to participate in a study exploring the impact shift work has on breast milk composition. Participants will be compensated with a $100 gift voucher.
Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...
Congratulations to Professor David Berlowitz, Dr Marnie Graco, and Dr Nicole Sheers who were recognised by Motor Neurone Disease (MND) Australia at a Parliament House event sponsored by the Parliamentary Friends of MND in Canberra last week.
WORLD SLEEP DAY ON 15TH MARCH 2024
The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 15th March 2024.
A/PROF MARK HOWARD AWARDED MAJOR MRFF GRANT
IBAS leads project to revolutionize Home Ventilation with $1.2 million grant for Assoc. Prof Mark Howard's research titled "Synchronise non-invasive ventilation at home".
PROF ANNE HOLLAND RECEIVES PRESTIGIOUS AWARD
Prof Anne Holland receives prestigious award for Excellent in Research Engagement and Impact from Monash University.
© 2024 Institute for Breathing and Sleep. All Rights Reserved. ABN 39 093 685 879
Powered by Helmut Design | Manage
